PIRAMAL PHARMA
Back to Balance Sheet
|
PIRAMAL PHARMA Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹3,393 Cr | ₹2,645 Cr | ₹3,812 Cr | ₹2,903 Cr | ₹2,560 Cr |
What is the latest Total Non-Current Liabilities ratio of PIRAMAL PHARMA ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹3,393 Cr |
| Mar2024 | ₹2,645 Cr |
| Mar2023 | ₹3,812 Cr |
| Mar2022 | ₹2,903 Cr |
| Mar2021 | ₹2,560 Cr |
How is Total Non-Current Liabilities of PIRAMAL PHARMA Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹3,393 Cr | 28.29 | |
| Mar2024 | ₹2,645 Cr | -30.62 | |
| Mar2023 | ₹3,812 Cr | 31.33 | |
| Mar2022 | ₹2,903 Cr | 13.37 | |
| Mar2021 | ₹2,560 Cr | - | |
Compare Total Non-Current Liabilities of peers of PIRAMAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PIRAMAL PHARMA | ₹22,319.2 Cr | 5.6% | -6.2% | -10.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,792.0 Cr | 1.4% | 1.2% | 13.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹178,152.0 Cr | -0.5% | -0.6% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹152,915.0 Cr | 2.1% | 1.5% | 42.2% | Stock Analytics | |
| CIPLA | ₹116,354.0 Cr | 6.4% | 1.6% | -3.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,681.0 Cr | 6.2% | 1.6% | 0.2% | Stock Analytics | |
PIRAMAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PIRAMAL PHARMA | 5.6% |
-6.2% |
-10.2% |
| SENSEX | -0.4% |
0.8% |
-5.3% |
You may also like the below Video Courses